Your browser doesn't support javascript.
loading
The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial.
Youssef, Jihad Georges; Lavin, Philip; Schoenfeld, David A; Lee, Richard A; Lenhardt, Rainer; Park, David J; Fernandez, Javier Perez; Morganroth, Melvin L; Javitt, Jonathan C; Jayaweera, Dushyantha.
Affiliation
  • Youssef JG; Houston Methodist Pulmonary Transplant Center, Houston Methodist Hospital, Houston, TX.
  • Lavin P; Department of Academic Pulmonology, Houston Methodist Hospital, Houston, TX.
  • Schoenfeld DA; Boston Biostatistics Research Foundation Inc, Framingham, MA.
  • Lee RA; Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Lenhardt R; University of California, Irvine, CA.
  • Park DJ; The University of Louisville, Louisville, KY.
  • Fernandez JP; St. Jude Medical Center, Fullerton, CA.
  • Morganroth ML; Baptist Hospital, Miami, FL.
  • Javitt JC; Oregon Clinic, Portland, OR.
  • Jayaweera D; Johns Hopkins University School of Medicine, Baltimore, MD.
Crit Care Med ; 50(11): 1545-1554, 2022 11 01.
Article in En | MEDLINE | ID: mdl-36044317
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Respiratory Insufficiency / COVID-19 Drug Treatment Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Crit Care Med Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Respiratory Insufficiency / COVID-19 Drug Treatment Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Crit Care Med Year: 2022 Type: Article